Cognitive Behavioral Therapy for People with Chronic Obstructive Pulmonary Disease: Rapid Review

• Main Authors: Williams MT, Johnston KN, Paquet C
• Format: Article
• Language: English
• Published: Dove Medical Press 2020-04-01
• Series: International Journal of COPD
• Subjects: cognitive behaviour therapy; chronic obstructive pulmonary disease; rapid review
• Online Access: https://www.dovepress.com/cognitive-behavioral-therapy-for-people-with-chronic-obstructive-pulmo-peer-reviewed-article-COPD

Marie T Williams,1 Kylie N Johnston,1 Catherine Paquet2 1Innovation, Implementation and Clinical Translation in Health (IIMPACT), School of Health Sciences, University of South Australia, Adelaide, SA 5000, Australia; 2Australian Centre of Precision Health, School of Health Sciences, University of South Australia, Adelaide, SA 5000, AustraliaCorrespondence: Marie T WilliamsInnovation, Implementation and Clinical Translation in Health (IIMPACT), School of Health Sciences, University of South Australia, North Terrace, Adelaide, SA 5000, AustraliaEmail [e-mail]: Cognitive behavioral therapy (CBT) is increasingly recommended in the management of people living with chronic obstructive pulmonary disease (COPD). This rapid review presents the evidence base for CBT for people with COPD and describes 1) the nature of CBT interventions and comparators in controlled trials (high or low resource intensity); and 2) factors influencing intervention effects on health outcomes (anxiety, depression, breathlessness, quality of life and exercise capacity). Primary studies reporting CBT interventions in adults with COPD were identified with data extracted by a single reviewer (20% of studies checked for data accuracy). Studies were synthesized descriptively with meta-analyses (random effects models) of controlled trials undertaken to report mean standardized effect sizes (95% CI) for health outcomes. Random effects meta-regression models explored whether CBT target, intervention dosage, intensity, facilitator profession, delivery mode, clinically significant anxiety/depression, trial design/quality and sample size predicted effect size. The search identified 33 primary studies published between 1996 and 2019 (controlled trials n=24, single group cohort n=6, case exemplars n=2, phenomenological n=1). Controlled trials frequently compared high-intensity CBT interventions against enhanced/usual care (n=12) or high-intensity CBT interventions against high-intensity comparators (n=11). When all controlled studies were included, small, significant improvements favoring CBT were evident across all health outcomes (SMD ranged from − 0.27 to 0.35, p< 0.05). When intensity dyads were considered, significant improvements were evident only when high-intensity CBT interventions were compared to enhanced usual care/usual care (SMDs ranged from − 0.45 to 0.54, p < 0.05). No other variable consistently predicted intervention effect sizes across all health outcomes. Overall, the evidence base supports the use of CBT for a range of health outcomes in people with COPD. Consistent benefits were evident when high-resource-intensive CBT interventions were compared to usual care. Low-resource-intensity CBT warrants further investigation in settings where cost of comprehensive care is prohibitive.Keywords: cognitive behavioral therapy, chronic obstructive pulmonary disease, rapid review